PIONEER NATURAL RESOURCES CO (PXD)       230.35  +0.52 (+0.23%)

230.35  +0.52 (+0.23%)

US7237871071 - Common Stock - After market: 230.35 0 (0%)


Fundamental Rating

6

Taking everything into account, PXD scores 6 out of 10 in our fundamental rating. PXD was compared to 388 industry peers in the Oil, Gas & Consumable Fuels industry. PXD has a medium financial health rating, its profitability is only medium as well. PXD is growing strongly while it is still valued neutral. This is a good combination!




Profitability

Profitability Rating

6

PXD has a Return On Assets of 19.90%. This is better than the industry average of 12.18%.
The Piotroski-F score of PXD is 9.00. This is a very strong score and indicates great health and profitability for PXD.

PXD's Return On Equity of 30.99% is in line with the rest of the industry. The industry average Return On Equity is 25.65%.
PXD's Profit Margin of 28.69% is in line with the rest of the industry. The industry average Profit Margin is 25.51%.
VS Industry

ROA (19.9%) VS Industry: 74% outperformed.

0.06
1,189.87

ROE (30.99%) VS Industry: 58% outperformed.

0.24
5,310.48

Profit Margin (28.69%) VS Industry: 58% outperformed.

0.07
268.29

Valuation

Valuation Rating

6

The Price/Earnings Ratio is 7.90, which indicates a rather cheap valuation of PXD.
The Forward Price/Earnings Ratio of 8.40 indicates a rather cheap valuation of PXD.
PXD's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
Compared to an average industry Price/Earning Ratio of 6.67, PXD is valued in line with its industry peers.

With a price book ratio of 2.38, PXD is valued correctly.
When comparing the Enterprise Value to EBITDA ratio of PXD to the average industry ratio of 4.31, PXD is valued in line with its industry peers.
Compared to an average industry price book ratio of 1.62, PXD is valued more expensive than its industry peers.
VS Industry

Price/Earnings (7.9) VS Industry: 42% outperformed.

1,225.00
0.07

Price/Book (2.38) VS Industry: 33% outperformed.

3,364.82
0.04

Enterprise Value/ EBITDA (4.39) VS Industry: 49% outperformed.

247.44
0.23

Growth

Growth Rating

7

The Earnings Per Share has grown by an impressive 206.30% over the past year.
Measured over the past 5 years, PXD shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.27% on average per year.
PXD shows a strong growth in Revenue. In the last year, the Revenue has grown by 73.20%.
PXD shows a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 38.48% yearly.

Based on estimates for the next 5 years, PXD will show a quite strong growth in Revenue. The Revenue will grow by 11.97% on average per year.
PXD is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 5.99% yearly.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A 27.27% 206.3% 146.11% 45.11% 22.89% 5.99%
Revenue38.48% 23.97% 73.2% 67.71% 24.92% 11.97% N/A

Health

Health Rating

6

An Altman-Z score of 4.46 indicates that PXD is not in any danger for bankruptcy at the moment.
The Altman-Z score of PXD is much better than the industry average of 2.15.
The Piotroski-F score of PXD is 9.00. This is a very strong score and indicates great health and profitability for PXD.
PXD has a Current Ratio of 1.03. This is a normal value and indicates that PXD is financially healthy and should not expect problems in meeting its short term obligations.

PXD has a Current Ratio comparable to the industry average, which is at 1.09.
PXD has a Quick Ratio comparable to the industry average, which is at 0.94.
The Debt to Equity ratio of PXD is in line with the industry averages.
PXD has a Quick Ratio of 1.03. This is a bad value and indicates that PXD is not financially healthy enough and could expect problems in meeting its short term obligations.
VS Industry

Debt/Equity (0.18) VS Industry: 56% outperformed.

31.33
0.00

Quick Ratio (0.93) VS Industry: 48% outperformed.

0.00
297.28

Current Ratio (1.03) VS Industry: 45% outperformed.

0.00
297.28

Altman-Z (4.46) VS Industry: 76% outperformed.

-283,883.15
1,166.96

Dividend

Dividend Rating

7

PXD has a Yearly Dividend Yield of 10.89%, which is a nice return.
PXD's Dividend Yield is rather good when compared to the industry average which is at 5.56. PXD pays more dividend than 91% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, PXD pays a better dividend.
The dividend of PXD is nicely growing with an annual growth rate of 177.39%!

PXD has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of PXD is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
PXD pays out 81.37% of its income as dividend. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (10.89%) VS Industry: 91% outperformed.

0.34
64.51

PIONEER NATURAL RESOURCES CO230.35

NYSE:PXD (1/31/2023, 7:04:00 PM)+0.52 (+0.23%)

After market: 230.35 0 (0%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Oil, Gas & Consumable Fuels
Earnings (Last) 10-27 2022-10-27/amc Earnings (Next) 02-14 2023-02-14
Inst Owners 90.26% Inst Owner Change -0.08%
Ins Owners 0.43% Ins Owner Change 1.42%
Market Cap 54.73B Analysts 73.51
Price Target 285.12 (23.78%)

Dividend
Dividend Yield 10.89% Dividend Growth 177.39%
DP 81.37% Ex-Date N/A

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) 2.72%
Min EPS beat(2) -0.51% Max EPS beat(2) 5.94%
EPS beat(4) 3 Avg EPS beat(4) 6.49%
Min EPS beat(4) -0.51% Max EPS beat(4) 11.01%
Revenue beat(2) 2 Avg Revenue beat(2) 52.51%
Min Revenue beat(2) 44.21% Max Revenue beat(2) 60.81%
Revenue beat(4) 4 Avg Revenue beat(4) 62.37%
Min Revenue beat(4) 44.21% Max Revenue beat(4) 75.35%
PT rev (1m) -0.38% EPS NQ rev (1m) 0%
EPS NY rev (1m) 0% Revenue NQ rev (1m) 0%
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE 7.9
Fwd PE 8.4
P/S 2.21
P/FCF 7.77
P/OCF 4.98
P/B 2.38
P/tB 2.41
EV/EBITDA 4.39
EPS(TTM) 29.16 EY 12.66%
EPS(NY) 27.44 Fwd EY 11.91%
FCF(TTM) 29.65 FCFY 12.87%
OCF(TTM) 46.23 OCFY 20.07%
SpS 104.31 BVpS 96.59
TBVpS 95.56 PEG (NY) 0.05
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA 19.9%
ROE 30.99%
ROIC 25.86%
ROICexc 27.45%
ROICexgc 27.67%
OM 42.72%
PM 28.69%
GM 54.76%
ROICexgc(3y) 9.46% ROICexcg growth 3Y 17.36%
ROICexcg growth 5Y N/A ROICexc(3y) 9.35%
ROICexc growth 3Y 17.74% ROICexc growth 5Y N/A
OM growth 3Y 18.84% OM growth 5Y N/A
PM growth 3Y 4.54% PM growth 5Y N/A
GM growth 3Y 4.58% GM growth 5Y 2.41%
F-Score 9 Asset Turnover 0.69

Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.74
Debt/EBITDA 0.4
Cap/Depr 154.69%
Profit Quality 99.04%
Current Ratio 1.03
Quick Ratio 0.93
Altman-Z 4.46
F-Score 9 WACC 12.21%
ROIC/WACC 2.27 Cap/Depr(3y) 141.72%
Cap/Depr(5y) 173.02% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 206.3% EPS 3Y 27.27%
EPS 5Y N/A EPS growth Q2Q 81.11%
EPS Next Y 146.11% EPS Next 2Y 45.11%
EPS Next 3Y 22.89% EPS Next 5Y 5.99%
Revenue growth 1Y 73.2% Revenue growth 3Y 23.97%
Revenue growth 5Y 38.48% Revenue growth Q2Q 22.09%
Revenue Next Year 67.71% Revenue Next 2Y 24.92%
Revenue Next 3Y 11.97% Revenue Next 5Y N/A
EBIT growth 1Y 137.56% EBIT growth 3Y 47.33%
EBIT growth 5Y N/A EBIT Next Year 209.82%
EBIT Next 3Y 37% EBIT Next 5Y 16.35%
FCF growth 1Y 2108.15% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y 362.68%
OCF growth 3Y 23.18% OCF growth 5Y 32.21%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA